NRXP
Price
$2.61
Change
+$0.29 (+12.50%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
55.15M
RNAC
Price
$9.80
Change
-$0.25 (-2.49%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
261.32M
Interact to see
Advertisement

NRXP vs RNAC

Header iconNRXP vs RNAC Comparison
Open Charts NRXP vs RNACBanner chart's image
NRX Pharmaceuticals
Price$2.61
Change+$0.29 (+12.50%)
Volume$699
Capitalization55.15M
Cartesian Therapeutics
Price$9.80
Change-$0.25 (-2.49%)
Volume$669
Capitalization261.32M
NRXP vs RNAC Comparison Chart in %
Loading...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRXP vs. RNAC commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRXP is a Buy and RNAC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (NRXP: $2.32 vs. RNAC: $10.05)
Brand notoriety: NRXP and RNAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRXP: 194% vs. RNAC: 65%
Market capitalization -- NRXP: $55.15M vs. RNAC: $261.32M
NRXP [@Biotechnology] is valued at $55.15M. RNAC’s [@Biotechnology] market capitalization is $261.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRXP’s FA Score shows that 0 FA rating(s) are green whileRNAC’s FA Score has 0 green FA rating(s).

  • NRXP’s FA Score: 0 green, 5 red.
  • RNAC’s FA Score: 0 green, 5 red.
According to our system of comparison, RNAC is a better buy in the long-term than NRXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRXP’s TA Score shows that 4 TA indicator(s) are bullish while RNAC’s TA Score has 4 bullish TA indicator(s).

  • NRXP’s TA Score: 4 bullish, 4 bearish.
  • RNAC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, NRXP is a better buy in the short-term than RNAC.

Price Growth

NRXP (@Biotechnology) experienced а -12.12% price change this week, while RNAC (@Biotechnology) price change was -10.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNAC($261M) has a higher market cap than NRXP($55.1M). RNAC has higher P/E ratio than NRXP: RNAC (1.98) vs NRXP (0.36). NRXP YTD gains are higher at: 5.455 vs. RNAC (-43.886). NRXP has higher annual earnings (EBITDA): -24.11M vs. RNAC (-118.73M). RNAC has more cash in the bank: 160M vs. NRXP (5.55M). NRXP has less debt than RNAC: NRXP (8.4M) vs RNAC (13.3M). RNAC has higher revenues than NRXP: RNAC (1.03M) vs NRXP (0).
NRXPRNACNRXP / RNAC
Capitalization55.1M261M21%
EBITDA-24.11M-118.73M20%
Gain YTD5.455-43.886-12%
P/E Ratio0.361.9818%
Revenue01.03M-
Total Cash5.55M160M3%
Total Debt8.4M13.3M63%
FUNDAMENTALS RATINGS
NRXP vs RNAC: Fundamental Ratings
NRXP
RNAC
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6365
P/E GROWTH RATING
1..100
9339
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NRXP's Valuation (53) in the null industry is somewhat better than the same rating for RNAC (100) in the Biotechnology industry. This means that NRXP’s stock grew somewhat faster than RNAC’s over the last 12 months.

NRXP's Profit vs Risk Rating (100) in the null industry is in the same range as RNAC (100) in the Biotechnology industry. This means that NRXP’s stock grew similarly to RNAC’s over the last 12 months.

NRXP's SMR Rating (100) in the null industry is in the same range as RNAC (100) in the Biotechnology industry. This means that NRXP’s stock grew similarly to RNAC’s over the last 12 months.

NRXP's Price Growth Rating (63) in the null industry is in the same range as RNAC (65) in the Biotechnology industry. This means that NRXP’s stock grew similarly to RNAC’s over the last 12 months.

RNAC's P/E Growth Rating (39) in the Biotechnology industry is somewhat better than the same rating for NRXP (93) in the null industry. This means that RNAC’s stock grew somewhat faster than NRXP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NRXPRNAC
RSI
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 5 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
85%
Momentum
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
85%
MACD
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSPHF0.86N/A
N/A
CSTONE PHARMACEUTICALS
CLPMF0.23N/A
N/A
Clip Money Inc.
CDAUF10.18N/A
N/A
Compass Digital Acquisition Corp.
XTPT0.74N/A
-0.05%
Xtra Energy Corp.
EBCOY10.26-0.38
-3.57%
Ebara Corp.

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with CDTX. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
-7.94%
CDTX - NRXP
85%
Closely correlated
+0.25%
NCNA - NRXP
84%
Closely correlated
-0.31%
RNAC - NRXP
83%
Closely correlated
-2.24%
ALLR - NRXP
83%
Closely correlated
+2.67%
TAOX - NRXP
82%
Closely correlated
-11.08%
More

RNAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAC has been closely correlated with NCNA. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
-2.24%
NCNA - RNAC
92%
Closely correlated
-0.31%
NBY - RNAC
91%
Closely correlated
+7.88%
TAOX - RNAC
91%
Closely correlated
-11.08%
SNGX - RNAC
89%
Closely correlated
+1.31%
KPRX - RNAC
89%
Closely correlated
N/A
More